Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

ClinicalTrials.gov ID: NCT03036124

Public ClinicalTrials.gov record NCT03036124. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure With Reduced Ejection Fraction

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effect of dapagliflozin on the incidence of worsening heart failure or cardiovascular death in patients with chronic heart failure with reduced ejection fraction

Study identification

NCT ID
NCT03036124
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
4,744 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 8, 2017 (Actual)
Primary completion
Jul 17, 2019 (Actual)
Completion
Jul 17, 2019 (Actual)
Last update posted
Sep 1, 2020

2017 – 2019

United States locations

U.S. sites
86
U.S. states
29
U.S. cities
77
Facility City State ZIP Site status
Research Site Fairhope Alabama 36532 —
Research Site Mobile Alabama 36608 —
Research Site Sheffield Alabama 35660 —
Research Site Bakersfield California 93309 —
Research Site Beverly Hills California 90211 —
Research Site Los Angeles California 90073 —
Research Site Palm Springs California 92262 —
Research Site Stockton California 95204 —
Research Site Torrance California 90502 —
Research Site Vista California 92083 —
Research Site Wilmington Delaware 19803 —
Research Site Boynton Beach Florida 33472 —
Research Site Jacksonville Florida 32209 —
Research Site Jacksonville Florida 32216 —
Research Site Lake Worth Florida 33461 —
Research Site Miami Florida 33125 —
Research Site Miami Florida 33155 —
Research Site Naples Florida 34102 —
Research Site New Smyrna Beach Florida 32169 —
Research Site Pembroke Pines Florida 33024 —
Research Site Port Charlotte Florida 33952 —
Research Site Saint Augustine Florida 32086 —
Research Site Wellington Florida 33449 —
Research Site Atlanta Georgia 30303 —
Research Site Cumming Georgia 30041 —
Research Site Tucker Georgia 30084 —
Research Site Hazel Crest Illinois 60429 —
Research Site Jerseyville Illinois 62052 —
Research Site Peoria Illinois 61614 —
Research Site Louisville Kentucky 40205 —
Research Site Alexandria Louisiana 71301 —
Research Site Chalmette Louisiana 70043 —
Research Site Bangor Maine 04401 —
Research Site Baltimore Maryland 21120 —
Research Site Baltimore Maryland 21228 —
Research Site Columbia Maryland 21044 —
Research Site Boston Massachusetts 02114 —
Research Site Haverhill Massachusetts 01830 —
Research Site Flint Michigan 48504 —
Research Site Flint Michigan 48532 —
Research Site Lansing Michigan 48910 —
Research Site Minneapolis Minnesota 55407 —
Research Site Minneapolis Minnesota 55417 —
Research Site Tupelo Mississippi 38801 —
Research Site Kansas City Missouri 64111 —
Research Site St Louis Missouri 63128 —
Research Site Great Falls Montana 59405 —
Research Site Grand Island Nebraska 68803 —
Research Site Lincoln Nebraska 68526 —
Research Site Omaha Nebraska 68105 —
Research Site Las Vegas Nevada 89128 —
Research Site Bridgewater New Jersey 08807 —
Research Site New Brunswick New Jersey 08901 —
Research Site Somerset New Jersey 08873 —
Research Site Buffalo New York 14203 —
Research Site Buffalo New York 14215 —
Research Site Cortlandt Manor New York 10567 —
Research Site New York New York 10001 —
Research Site Orchard Park New York 14127 —
Research Site Poughkeepsie New York 12601 —
Research Site Rosedale New York 11422 —
Research Site The Bronx New York 10459 —
Research Site Burlington North Carolina 27215 —
Research Site Cleveland Ohio 44106-6010 —
Research Site Columbus Ohio 43210 —
Research Site Altoona Pennsylvania 16602 —
Research Site Philadelphia Pennsylvania 19104 —
Research Site Pittsburgh Pennsylvania 15212 —
Research Site Pittsburgh Pennsylvania 15240 —
Research Site Rapid City South Dakota 57701 —
Research Site Knoxville Tennessee 37912 —
Research Site Memphis Tennessee 38104 —
Research Site Nashville Tennessee 37212 —
Research Site Tullahoma Tennessee 37388 —
Research Site Beaumont Texas 77702 —
Research Site Dallas Texas 75231 —
Research Site Dallas Texas 75246 —
Research Site Houston Texas 77002 —
Research Site Kingwood Texas 77339 —
Research Site San Antonio Texas 78234 —
Research Site Tyler Texas 75701 —
Research Site Farmington Utah 84025 —
Research Site Falls Church Virginia 22042 —
Research Site Richmond Virginia 23298 —
Research Site Seattle Washington 98101 —
Research Site Seattle Washington 98195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 333 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03036124, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 1, 2020 · Synced Nov 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03036124 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →